DULCOLAX Dragee's gastrointestinal tablet socket, 100 pcs

Instructions for use for DULCOLAX Dragee's gastrointestinal tablet socket, 100 pcs

Detailed instructions for DULCOLAX Dragee's gastrointestinal tablet socket, 100 pcs

Field of use

Dulcolax Dragées can in the event of constipation (pack size: 100 pcs) are at short notice in the event of intestinal and constipation (constipation), in the case of diseases that require relieved intestinal emptying and to prepare operations and measures to identify diseases (diagnostic interventions ) applied.

Mode of action

Dulcolax Dragées can in the event of constipation (pack size: 100 pc) increase the water and electrolyte tax into the intestinal lumen. Anti -resorptive and hydragogue effects were also described. This leads to a reduction in consistency and increasing the volume of the stool and thus reflective to stimulate the self -movement of the intestine.

The acid -resistant special covering of the Dulcolax Dragées can in the event of constipation (pack size: 100 pc) ensures that the active ingredient bisacodyl is only released in the large intestine.

Active ingredients / ingredients / ingredients

A dragea of the Dulcolax Dragées can in the event of constipation (pack size: 100 pc):

• 5mg bisacodyyl

as other components

Arabic rubber, Carnauba wax, quinol ringing, yellow orange S, titanium dioxide, bleached wax, glycerol, corn starch , 35 mg, Macrogol 6000, magnesium diesteary, Eudagit (r) S 100, 20 mg Saccharosis, talcum, soluble strength, native castor oil.

Contradictions

In the case of known hypersensitivity to the active ingredient or one of the other components, the drug should not be applied.

The product should not be taken together with milk or other the stomach acid, otherwise the effect can be impaired.

This drug must not be used in the event of an intestinal lock, in the case of acute and surgically treating abdominal pain (such as acute appendicitis) and in children under 2 years. In the event of acute gastrointestinal diseases and in the event of disorders of the water and mineral balance, the drug should also not be used.

dosage

The Dulcolax Dragées can in the event of constipation (package size: 100 pc) should preferably be taken in the evening before going to bed, they can fully develop their effect overnight (occurrence of effects after 6 - 12 h).

The dosage for children from 2 years is 1 Dulcolax Dragées can in the event of constipation (package size: 100 pc)/day, adults and children from 10 years take 1 to 2 Dulcolax Dragées Case for constipation (pack size: 100 pcs)/day.
The intake takes place with plenty of liquid (preferably a glass of water, but no milk).

The product should not, together with milk or other stomach acid, influence the stomach acid (e.g. Means against heartburn), otherwise the effect can be impaired.

Evering

• Take in the Dragees Unzukaut with sufficient fluid (preferably a glass of water, but no milk).

Patient information

• Warnings and Precautions
  • Please speak to your doctor or pharmacist before taking the medicine.
  • Laxatives should only take place without medical clarification.
  • In the event of chronic constipation, you should ask your doctor for advice before taking it.
  • An increased loss of fluid can lead to drying out (dehydrated). In certain circumstances (e.g. in patients with impaired kidney function or in older people) this can have harmful effects. In such cases, taking the drug should be interrupted and only continued under medical supervision.
  • Patients reported blood admixtures in the stool, which were generally described as weak and stopped themselves.
  • In patients who have taken this medicine, dizziness or short -term seizures of consciousness (syncope) were reported. According to the corresponding case reports, these are presumably syncope that either go back to the laxative process itself, pressing or on circulatory reactions due to abdominal pain.
• Children
  • The dragees must not be used in children under 2 years.
  • In children, the dragees should only be applied to medical instruction.

• Wateriness and ability to operate machines
  • No studies on the effect on the traffic and the ability to use machines were carried out.
  • Please note that side effects can occur that could theoretically impair the management of vehicles and operating machines.

Pregnancy

• If you are pregnant or breastfeed, or if you suspect that you are pregnant or intend to become pregnant, ask your doctor or pharmacist for advice before taking this drug.
• Pregnancy
  • Since the introduction, no undesirable or damaging effects have become known during pregnancy. Studies on the application during pregnancy were not carried out.
  • Therefore, like all medicines, the drages should only be used after pregnancy after consultation with your doctor.
• Breastfeeding
  • It has been shown that the active ingredient does not transfer to breast milk. The drages can therefore be used during breastfeeding.

Hints

Dulcolax® Dragées. Active ingredient: bisacodyl application area: for use in the event of constipation, in the case of diseases that require relieved intestinal emptying and for intestinal emptying for treatment measures and measures to identify diseases (therapeutic and diagnost. Interventions) on the intestine. Note: Like other laxatives, Dulcolax® Dragées without a medical clarification of the cause of the constipation should not be taken daily or over a longer period of time. Contains the dye yellow orange s, lactose and sucrose. Does not contribute to weight loss. The simultaneous use of other laxatives can increase the side effects in the gastrointestinal tract. Note leaflet. Pharmacy.

Read the package supplement and ask your doctor or pharmacist for risks and side effects.

Sanofi-Aventis Deutschland GmbH, 65926 Frankfurt am Main.

As of September 2017 (Sade.dulc1.18.01.0103)